Page last updated: 2024-12-10

bc 264

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BC 264: a selective CCK-B agonist; do not confuse with pBC 264 (propionyl-BC 264) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5311016
MeSH IDM0224597

Synonyms (6)

Synonym
gtpl897
bc264
bc 264
bc-264
(3s)-3-[[(2s)-2-[[(2s)-2-[(3-amino-3-oxopropanoyl)amino]-3-(1h-indol-3-yl)propanoyl]-methylamino]hexanoyl]amino]-4-[[(2s)-1-[[(1s)-1-[[(2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-sulfooxyphenyl)propanoyl]amino]pentyl]amino]-1-oxo-3-phenylpropan-2-
Q27074938

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346921Rat CCK2 receptor (Cholecystokinin receptors)2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Synthesis and biological characterisation of [3H]BBL454, a new CCK2 selective radiolabelled agonist displaying original pharmacological properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's29 (87.88)18.2507
2000's3 (9.09)29.6817
2010's1 (3.03)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.34 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index28.10 (26.88)
Search Engine Supply Index2.80 (0.95)

This Compound (23.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]